First-Line Erlotinib Therapy Until and Beyond Response Evaluation Criteria in Solid Tumors Progression in Asian Patients With Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer - Concepedia

Concepedia

Publication | Closed Access

First-Line Erlotinib Therapy Until and Beyond Response Evaluation Criteria in Solid Tumors Progression in Asian Patients With Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer

225

Citations

27

References

2015

Year

Keunchil Park, Chong‐Jen Yu, Sang-We Kim, Meng-Chih Lin, Virote Sriuranpong, Chun-Ming Tsai, Jong-Seok Lee, Jin Hyoung Kang, K.C. Chan, Pablo Ernesto Pérez,

Abstract

clinicaltrials.gov Identifier: NCT01310036.

References

	Year	Citations

Page 1